
Ketorolac (0.5% w/v) + Ofloxacin (0.3% w/v)
Active composition
+1 more active ingredient
Ketorolac inhibits cyclooxygenase enzymes, leading to decreased production of prostaglandins, which mediate pain and inflammation.
Ofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Ofloskat Eye Drop is a sterile ophthalmic solution containing Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Ketorolac 0.5% w/v, a nonsteroidal anti-inflammatory drug (NSAID). This combination is indicated for the treatment of bacterial ocular infections accompanied by inflammation and pain. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible gram-positive and gram-negative pathogens. Ketorolac provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, reducing the synthesis of prostaglandins responsible for inflammation and pain. Ofloskat Eye Drop is commonly prescribed for bacterial conjunctivitis, keratitis, and postoperative ocular inflammation where infection and inflammation coexist. The formulation ensures rapid relief from symptoms such as redness, swelling, and discomfort while addressing the underlying infection. It is recommended to be used as directed by an ophthalmologist, typically instilled into the affected eye(s) several times daily. Caution is advised in patients with hypersensitivity to fluoroquinolones or NSAIDs. Proper administration and adherence to the prescribed regimen are essential to achieve optimal therapeutic outcomes and prevent resistance development.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Ofloskat Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Ofloskat Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Ofloskat Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Ofloskat Eye Drop

Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Ketorolac inhibits cyclooxygenase enzymes, leading to decreased production of prostaglandins, which mediate pain and inflammation.
Ofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Ofloskat Eye Drop is a sterile ophthalmic solution containing Ofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic, and Ketorolac 0.5% w/v, a nonsteroidal anti-inflammatory drug (NSAID). This combination is indicated for the treatment of bacterial ocular infections accompanied by inflammation and pain. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible gram-positive and gram-negative pathogens. Ketorolac provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, reducing the synthesis of prostaglandins responsible for inflammation and pain. Ofloskat Eye Drop is commonly prescribed for bacterial conjunctivitis, keratitis, and postoperative ocular inflammation where infection and inflammation coexist. The formulation ensures rapid relief from symptoms such as redness, swelling, and discomfort while addressing the underlying infection. It is recommended to be used as directed by an ophthalmologist, typically instilled into the affected eye(s) several times daily. Caution is advised in patients with hypersensitivity to fluoroquinolones or NSAIDs. Proper administration and adherence to the prescribed regimen are essential to achieve optimal therapeutic outcomes and prevent resistance development.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Ofloskat Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Ofloskat Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Ofloskat Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Ofloskat Eye Drop















